Sofwave™ offers a unique approach to skin treatments using proprietary high-frequency, high-intensity Ultrasound Beam technology, SUPERB™. This breakthrough technology is the best option for non-invasive, no-downtime aesthetic treatments, providing physicians with innovative yet simple, effective, and safe aesthetic solutions for their patients. The Sofwave™ device is FDA-cleared and CE-marked as a non-invasive aesthetic treatment to reduce facial lines and wrinkles, lift the eyebrow, lift lax submental and neck tissue, and short-term improvement in the appearance of cellulite.
Sofwave™ empowers physicians through a high-touch approach, a dedicated expert team, and innovative best-in-class delegatable technology that delivers consistent results regardless of skin type and is not sun sensitive or requires further care.
Heritage of Innovation
From key founders of the aesthetic industry, Sofwave™ Medical brings a novel approach to non-invasive skin treatments using proprietary Synchronous Ultrasound Parallel Beam Technology SUPERB™.
Game-Changing Approach
Sofwave™ Medical’s breakthrough technology brings a new standard of care to aesthetic treatments, providing physicians with smart yet simple, effective, and safe treatments for their patients.
Commitment & Passion
Driven by experience and passion, Sofwave™ Medical is a fast-growing medical aesthetic technology innovator committed to developing cutting-edge technologies for the global aesthetic market.
News
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights
Second quarter revenue of $12.4M, +53% year-over-year growth Second quarter pulse recurring revenue of $3.3M, +100% year-over-year growth First half revenue of $22.8M, +67% year-over-year growth, gross margin of 74.2%.
Sofwave Medical Receives 510(k) Marketing Clearance For Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology
Pure Impact™ is a unique muscle toning and firming system designed to stimulate multiple muscle groups and body areas simultaneously.
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars
FDA clearance supported by a clinical study (n=67) and demonstrated treatment safety and efficacy utilizing SUPERB™, 97% of the treated participants in the trial showed improvement in the appearance of acne scars as assessed by masked evaluations
Job ads
Contact this exhibitor
- ST8 7FE,
- Stoke on Trent,
- United Kingdom